Open AccessSynergistic effect of vancomycin combined with cefotaxime, imipenem, or meropenem against Staphylococcus aureus with reduced susceptibility to vancomycin
Author(s) -
Arpasiri Srisrattakarn,
Chonthicha Chaiyapoke,
Sirikarn Booncharoen,
Sujintana Wongthong,
Aroonwadee Chanawong,
Patcharaporn Tippayawat,
Ratree Tavichakorntrakool,
Aroonlug Lulitad
Publication year - 2021
Publication title -
turkish journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.277
H-Index - 27
eISSN - 1303-6165
pISSN - 1300-0144
DOI - 10.3906/sag-1910-166
Subject(s) - meropenem , imipenem , vancomycin , cefotaxime , microbiology and biotechnology , medicine , staphylococcus aureus , antibiotics , biology , bacteria , antibiotic resistance , genetics
We investigated the synergistic effect between vancomycin and β-lactams against vancomycin-susceptible (VSSA) and nonsusceptible MRSA isolates [heterogeneous vancomycin-intermediate S. aureus (hVISA) and VISA].